Gretchen Báez Bergado

Title: Innovations in Cancer Treatment by Gretchen Báez Bergado

Introduction

Gretchen Báez Bergado is a prominent inventor based in Havana, Cuba. She has made significant contributions to the field of biotechnology and medicine, particularly in the treatment of carcinomas. Her innovative approach focuses on the selection and treatment of patients with specific cancer characteristics.

Latest Patents

Gretchen holds a patent for a method aimed at treating patients with carcinomas of epithelial origin. This method is particularly relevant for those who co-express the HER1 and HER2 receptors without increased expression or with the presence of RAS activating mutations. The invention utilizes bivalent vaccine compositions that include the extracellular domains of the HER1 and HER2 receptors, along with very small proteoliposomes derived from outer membrane proteins and GM3 ganglioside as an adjuvant. This method is especially beneficial for patients whose expression levels of HER1 and HER2 do not permit the therapeutic effects of monoclonal antibodies.

Career Highlights

Gretchen Báez Bergado is affiliated with the Centro de Inmunología Molecular, where she continues to advance her research and innovations in cancer treatment. Her work has garnered attention for its potential to improve patient outcomes in oncology.

Collaborations

Gretchen collaborates with notable colleagues, including Belinda Sánchez Ramírez and Narjara González Suárez. These partnerships enhance her research efforts and contribute to the development of effective treatment methods.

Conclusion

Gretchen Báez Bergado's innovative work in cancer treatment exemplifies the impact of biotechnology on medicine. Her patented method offers new hope for patients with specific carcinoma characteristics, showcasing the importance of continued research and collaboration in the field.